Literature DB >> 4343677

Biological effects of Corynebacterium parvum. 3. Amplification of resistance and impairment of active immunity to murine tumours.

S E Smith, M T Scott.   

Abstract

The effect of pre-treatment with Corynebacterium parvum on the growth in vivo of a range of experimental mouse tumours with differing characteristics has been investigated. Varying degrees of protection were observed which were generally greater with the more immunogenic tumours. Administration of C. parvum 7 days before immunization with irradiated tumour cells diminished the protective effect which could be obtained by immunization alone. The possible basis for these seemingly conflicting influences is considered.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4343677      PMCID: PMC2008632          DOI: 10.1038/bjc.1972.47

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

Review 1.  Active immunotherapy.

Authors:  G Mathé
Journal:  Adv Cancer Res       Date:  1971       Impact factor: 6.242

2.  Depression of delayed hypersensitivity by pretreatment with Freund-type adjuvants. I. Description of the phenomenon.

Authors:  G L Asherson; G G Allwood
Journal:  Clin Exp Immunol       Date:  1971-08       Impact factor: 4.330

3.  Enhanced resistance of mice to infection with bacteria following pre-treatment with Corynebacterium parvum.

Authors:  C Adlam; E S Broughton; M T Scott
Journal:  Nat New Biol       Date:  1972-02-16

4.  [The protective effect of Corynebacterium parvum against grafts of AKR leukemia. Relation with hepatic catalase activity and the phagocytic function of the reticulo-endothelial system].

Authors:  A Lamensans; C Stiffel; M F Mollier; M Laurent; D Mouton; G Biozzi
Journal:  Rev Fr Etud Clin Biol       Date:  1968-10

5.  Endotoxin and double stranded RNA render macrophages cytotoxic.

Authors:  P Alexander; R Evans
Journal:  Nat New Biol       Date:  1971-07-21

6.  Increased nonspecific resstance to malaria produced by administration of killed Corynebacterium parvum.

Authors:  R S Nussenzweig
Journal:  Exp Parasitol       Date:  1967-10       Impact factor: 2.011

7.  Inhibition of tumour growth by administration of killed corynebacterium parvum.

Authors:  B N Halpern; G Biozzi; C Stiffel; D Mouton
Journal:  Nature       Date:  1966-11-19       Impact factor: 49.962

8.  Active immunotherapy with Corynebacterium parvum and chemotherapy in murine fibrosarcomas.

Authors:  G A Currie
Journal:  Br Med J       Date:  1970-02-28

9.  Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.

Authors:  G Mathé; P Pouillart; F Lapeyraque
Journal:  Br J Cancer       Date:  1969-12       Impact factor: 7.640

10.  Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogenic hosts.

Authors:  M F Woodruff; J L Boak
Journal:  Br J Cancer       Date:  1966-06       Impact factor: 7.640

View more
  24 in total

1.  The effect of Corynebacterium parvum on the humoral and cellular immune systems in patients with breast cancer.

Authors:  J P Minton; J L Rossio; B Dixon; M C Dodd
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

2.  Haematological changes and iron metabolism in rats after administration of Corynebacterium parvum.

Authors:  B Brozovic; V S Sljivić; G W Warr
Journal:  Br J Exp Pathol       Date:  1975-04

Review 3.  Lipid characteristics in metastatic cells.

Authors:  S Ruggieri; G Mugnai; A Mannini; L Calorini; A Fallani; E Barletta; G Mannori; O Cecconi
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

4.  Effect of Corynebacterium parvum treatment on the growth of Salmonella enteritidis in mice.

Authors:  F M Collins; M T Scott
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

Review 5.  Vaccines and cell-mediated immunity.

Authors:  F M Collins
Journal:  Bacteriol Rev       Date:  1974-12

6.  In vivo localization of radioiodinated peanut lectin in a murine TA3/Ha mammary carcinoma model.

Authors:  A Shysh; S M Eu; A A Noujaim; M R Suresh; B M Longenecker
Journal:  Eur J Nucl Med       Date:  1985

7.  Dichotomy between macrophage activation and degree of protection against Listeria monocytogenes and Toxoplasma gondii in mice stimulated with Corynebacterium parvum.

Authors:  J E Swartzberg; J L Krahenbuhl; J S Remington
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

8.  Enhancement of resistance and suppression of immunization against experimental Trypanosoma cruzi infection by Corynebacterium parvum.

Authors:  F Kierszenbaum
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

9.  Studies on natural killer cell activity and the influence of Corynebacterium parvum on murine T-cell leukemogenesis induced by butylnitrosourea.

Authors:  H J Seidel; W Stolz
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

10.  Radioiodinated peanut lectin: a potential radiopharmaceutical for immunodetection of carcinoma expressing the T antigen.

Authors:  P L Zabel; A A Noujaim; A Shysh; J Bray
Journal:  Eur J Nucl Med       Date:  1983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.